Amy Raskopf | Head, IR |
Saundra Pelletier | President, CEO & Director |
Justin File | CFO |
Russell Barrans | Chief Commercial Officer |
Kelly Culwell | Chief Medical Officer |
David Amsellem | Piper Sandler & Co. |
Leland Gershell | Oppenheimer |
Raghuram Selvaraju | H.C. Wainwright & Co. |
Ladies and gentlemen, thank you for standing by, and welcome to the Evofem Biosciences Second Quarter 2020 Financial Results Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Ms. Amy Raskopf, Evofem Biosciences Head of Investor Relations. Ma'am, please go ahead.